SWEDISH ORPHAN BIOVIT.SK1
SWEDISH ORPHAN BIOVIT.SK1/ SE0000872095 /
B6E
10/16/2024 3:22:34 PM
|
Chg.
+0.060
|
Volume |
Bid3:22:34 PM |
Ask3:22:34 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
25.900EUR
|
+0.23%
|
- Turnover: - |
25.900Bid Size: - |
25.980Ask Size: - |
9.22 bill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
7.47 SEK |
-16.26% |
EPS Diluted: |
- SEK |
-16.40% |
Revenues per Share: |
62.43 SEK |
2.93% |
Book Value per Share: |
95.57 SEK |
11.63% |
Cash Flow per Share: |
12.61 SEK |
-16.23% |
Dividend per Share: |
- SEK |
- |
Total |
in mill. |
|
Revenues: |
22,123.00 SEK |
17.74% |
Net Income: |
2,409.00 SEK |
-8.68% |
Operating Cash Flow: |
4,470.00 SEK |
- |
Cash and Cash Equivalents: |
904.00 SEK |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
39.46 |
35.74 |
P/S Ratio: |
4.72 |
4.28 |
P/BV ratio: |
3.08 |
2.79 |
P/CF Ratio: |
23.37 |
21.17 |
PEG: |
-2.43 |
-2.20 |
Earnings Yield: |
2.53% |
2.80% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
9.22 bill. EUR |
8.5 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
5.2 mill. EUR |
4.8 mill. EUR |
Shares Outstanding: |
354.36 mill. |
|
Profitability
Gross Profit Margin: |
77.42% |
EBIT Margin: |
18.38% |
Net Profit Margin: |
10.89% |
Return on Equity: |
7.11% |
Return on Assets: |
3.25% |
Financial Strength
Liquidity I / Cash Ratio: |
4.73% |
Liquidity II / Quick Ratio: |
31.80% |
Liquidity III / Current Ratio: |
66.36% |
Debt / Equity Ratio: |
118.58% |
Dynam. Debt / Equity Ratio: |
898.43% |
Efficiency
Employees: |
1,772 |
Personal Expenses / Employee: |
- SEK |
Revenues / Employee: |
12,484,762.98 SEK |
Net Income / Employee: |
1,359,480.81 SEK |
Total Assets / Employee: |
41,775,959.37 SEK |
* Fiscal Year End: |
12/31/2023 |
Accounting Standard: |
IFRS |